Merix raises $39.5 million

Immunotherapy company Merix (Durham, N.C.) raised $39.5 million in a venture financing. Investors included Sofinov; Techno Venture Management; ABN Amro Ventures; GeneChem Therapeutics Venture Fund; Oa...